(Bloomberg) -- China’s probe into AstraZeneca Plc has reached its ... In 2013, GSK Plc admitted that its sales organization ...

[Photo provided to China.org.cn] To better facilitate the development of first-in-class new drugs in China, AstraZeneca upgraded its R&D center in Shanghai in 2021, with all projects now being ...

AstraZeneca has shown its commitment to China amid investigations into its executives and activities, outlining plans to establish a global strategic R&D center in Beijing as part of a $2.5 ...

Pascal Soriot, AstraZeneca’s chief executive, says the investment ‘reflects our belief in the world-class life sciences ecosystem in Beijing’ - Zach Gibson/Bloomberg AstraZeneca has unveiled ...

Five current and former AstraZeneca employees have reportedly been detained in China in connection with a pair of investigations. The investigations concern the importation of an unapproved liver ...

The U.K. pharmaceutical company AstraZeneca has become the largest multinational drugmaker in China, drawing 13% of its $5.8 billion in revenue last year from there, against a backdrop of an acute ...

LONDON, Nov 6 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not know the reason ...

AstraZeneca AZN1.05%increase; green up pointing triangle plans to invest $2.5 billion in China over five years to build a research-and-development center and strike deals with local biotechnology ...

AstraZeneca Says Current, Former Executives Involved in China Probe The company’s China president has been detained by authorities Astra has attempted to quell concerns over the investigation ...